WebMD News from HealthDay
April 29, 2016 -- The first generic version of the cholesterol -lowering statin drug Crestor ( rosuvastatin calcium) tablets was approved Friday by the U.S. Food and Drug Administration.
The generic version from Watson Pharmaceuticals Inc. of New Jersey received approval to market generic rosuvastatin calcium in multiple strengths for certain uses
in combination with diet for the treatment of high triglycerides (hypertriglyceridemia) in adults in combination with diet for treatment of patients with primary dysbetalipoproteinemia (Type III Hyperlipoproteinemia), a disorder associated with improper breakdown of cholesterol and triglycerides either alone or in combination with other cholesterol treatment(s) for adult patients with homozygous familial hypercholesterolemia , a disorder associated with high levels of "bad" low-density lipoprotein ( LDL ) cholesterol.
Copyright Â© 2013-2016 HealthDay.
All rights reserved.
Continue reading below...